We are live on ! Find out more
XLRN

Acceleron Pharma
XLRN

Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

110 hedge funds and large institutions have $966M invested in Acceleron Pharma in 2014 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

217% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 12

105% more call options, than puts

Call options by funds: $11.8M | Put options by funds: $5.74M

57% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 23

51% more capital invested

Capital invested by funds: $639M → $966M (+$327M)

31% more funds holding

Funds holding: 84 → 110 (+26)

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

Holders
110
Holders Change
+26
Holders Change %
+30.95%
% of All Funds
2.93%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.16%
New
38
Increased
36
Reduced
23
Closed
12
Calls
$11.8M
Puts
$5.74M
Net Calls
+$6.02M
Net Calls Change
+$3.43M

Top Buyers

Rank Fund Capital Flow
1
ORI
Oak Ridge Investments
Illinois
+$21.3M
2
BFA
BlackRock Fund Advisors
California
+$15.2M
3
CCP
Clough Capital Partners
Massachusetts
+$14.4M
4
ICAP
Independence Capital Asset Partners
Colorado
+$11.8M
5
GIM
Granahan Investment Management
Massachusetts
+$10.7M

Top Sellers

Rank Fund Capital Flow
1
QF
QVT Financial
New York
-$8.05M
2
PVMCI
Polaris Venture Management Co IV
Massachusetts
-$7.78M
3
DVC
Deer VII & Co
New York
-$5.29M
4
CAM
Cormorant Asset Management
Massachusetts
-$5.23M
5
PA
Perceptive Advisors
New York
-$4.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
Thrivent Financial for Lutherans
51
Thrivent Financial for Lutherans
Minnesota
$1.45M -$105K -3,000 -7%
California Public Employees Retirement System
52
California Public Employees Retirement System
California
$1.43M +$1.22M +35,002 New
D.E. Shaw & Co
53
D.E. Shaw & Co
New York
$1.32M +$1.18M +33,779 New
BlackRock
54
BlackRock
New York
$1.26M +$1.11M +31,900 +8,329%
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$1.19M +$4.53K +130 +0.4%
BBA
56
Baker Bros. Advisors
New York
$1.12M – – –
SGAM
57
Smith Group Asset Management
Texas
$970K -$87.5K -2,510 -9%
ProShare Advisors
58
ProShare Advisors
Maryland
$970K +$868K +24,893 New
Ameriprise
59
Ameriprise
Minnesota
$908K +$813K +23,317 New
Teacher Retirement System of Texas
60
Teacher Retirement System of Texas
Texas
$868K +$758K +21,754 +4,167%
AP
61
AlpInvest Partners
Netherlands
$842K +$753K +21,603 New
Morgan Stanley
62
Morgan Stanley
New York
$819K -$4.18K -120 -0.6%
KCM
63
Kennedy Capital Management
Missouri
$786K +$703K +20,168 New
AQR Capital Management
64
AQR Capital Management
Connecticut
$736K +$659K +18,900 New
State of New Jersey Common Pension Fund D
65
State of New Jersey Common Pension Fund D
New Jersey
$701K – – –
Goldman Sachs
66
Goldman Sachs
New York
$639K +$572K +16,399 New
Citigroup
67
Citigroup
New York
$638K +$403K +11,577 +241%
Swiss National Bank
68
Swiss National Bank
Switzerland
$588K – – –
GPCM
69
Granite Point Capital Management
Massachusetts
$584K – – –
State Board of Administration of Florida Retirement System
70
State Board of Administration of Florida Retirement System
Florida
$577K – – –
Connor, Clark & Lunn Investment Management (CC&L)
71
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$542K +$484K +13,900 New
Simplex Trading
72
Simplex Trading
Illinois
$530K +$474K +13,602 New
MLICM
73
Metropolitan Life Insurance Company (MetLife)
New York
$506K – – –
RhumbLine Advisers
74
RhumbLine Advisers
Massachusetts
$498K -$19.2K -550 -4%
NFA
75
Nationwide Fund Advisors
Ohio
$487K -$5.33K -153 -1%
1 2
3
4 5

XLRN Hedge Fund Activity: Q4 2014 in Review

110 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Acceleron Pharma (XLRN) for Q4 2014, worth a combined $966M — up 51% from $639M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new XLRN positions and 12 closed out — a net gain of 26 holders — while 36 added to existing stakes and 23 trimmed.

The largest buyer was Oak Ridge Investments, adding an estimated $21.3M. The largest seller was QVT Financial, cutting an estimated $8.05M.

  • 110 institutional investors held Acceleron Pharma (XLRN) as of Q4 2014, up from 84 in Q3 2014.
  • Funds reported $966M of Acceleron Pharma stock for Q4 2014, up 51% quarter-over-quarter.
  • 38 funds opened new Acceleron Pharma positions in Q4 2014 and 12 closed out, a net change of +26 holders.
  • The largest Acceleron Pharma buyer in Q4 2014 was Oak Ridge Investments, an estimated $21.3M added.
  • The largest Acceleron Pharma seller in Q4 2014 was QVT Financial, an estimated $8.05M sold.

Based on aggregated 13F filings for Q4 2014.